Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
29,224,066
-
Shares change
-
+734,996
-
Total reported value, excl. options
-
$409,245,732
-
Value change
-
+$31,590,430
-
Put/Call ratio
-
128%
-
Number of buys
-
56
-
Number of sells
-
-49
-
Price
-
$14.01
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2016
139 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2016.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,224,066 shares
of 80,437,135 outstanding shares and own 36.33% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,648,386 shares), CAMBER CAPITAL MANAGEMENT LLC (2,000,000 shares), VANGUARD GROUP INC (1,849,447 shares), BlackRock Fund Advisors (1,384,550 shares), BB BIOTECH AG (1,182,912 shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (1,174,730 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,173,378 shares), BlackRock Institutional Trust Company, N.A. (899,246 shares), Sectoral Asset Management Inc (779,998 shares), and D. E. Shaw & Co., Inc. (751,177 shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.